BIOMAT Database Logo BIOMAT Database Logo

CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo. 2007

Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Indiana University School of Medicine, Department of Microbiology and Immunology, 635 Barnhill Drive, Room 420, Indianapolis, IN 46202, USA.

Human immunodeficiency virus type 1 (HIV-1) infection of individuals carrying the two alleles of the CCR5Delta32 mutation (CCR5(-/-)) has rarely been reported, but how the virus overcomes the CCR5Delta32 protective effect in these cases has not been delineated. We have investigated this in 6 infected (HIV(+)) and 25 HIV(-) CCR5(-/-) individuals. CD4(+) T lymphocytes isolated from HIV(-) CCR5(-/-) peripheral blood mononuclear cells (PBMCs) showed lower levels of CXCR4 expression that correlated with lower X4 Env-mediated fusion. Endogenous CCR5Delta32 protein was detected in all HIV(-) CCR5(-/-) PBMC samples (n = 25) but not in four of six unrelated HIV(+) CCR5(-/-) PBMC samples. Low levels were detected in another two HIV(+) CCR5(-/-) PBMC samples. The expression of adenovirus 5 (Ad5)-encoded CCR5Delta32 protein restored the protective effect in PBMCs from three HIV(+) CCR5(-/-) individuals but failed to restore the protective effect in PBMCs isolated from another three HIV(+) CCR5(-/-) individuals. In the latter samples, pulse-chase analyses demonstrated the disappearance of endogenous Ad5-encoded CCR5Delta32 protein and the accumulation of Ad5-encoded CCR5 during the chase periods. PBMCs isolated from CCR5(-/-) individuals showed resistance to primary X4 but were readily infected by a lab-adapted X4 strain. Low levels of Ad5-encoded CCR5Delta32 protein conferred resistance to primary X4 but not to lab-adapted X4 virus. These data provide strong support for the hypothesis that the CCR5Delta32 protein actively confers resistance to HIV-1 in vivo and suggest that the loss or reduction of CCR5Delta32 protein expression may account for HIV-1 infection of CCR5(-/-) individuals. The results also suggest that other cellular or virally induced factors may be involved in the stability of CCR5Delta32 protein.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015686 Gene Products, env Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. env Gene Products,env Polyproteins,env Protein,env Antigens,env Glycoproteins,env Polyprotein,Antigens, env,Polyprotein, env,Polyproteins, env
D053586 Virus Internalization The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by translocation of the whole virus across the cell membrane, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by fusion of the membrane of infected cells with the membrane of non-infected cells causing SYNCYTIA to be formed. Viral Entry,Viral Internalization,Viral Membrane Fusion,Virus Entry,Virus Membrane Fusion,Entry, Viral,Entry, Virus,Fusion, Viral Membrane,Internalization, Viral,Internalization, Virus,Membrane Fusion, Viral
D019713 Receptors, CCR5 CCR receptors with specificity for CHEMOKINE CCL3; CHEMOKINE CCL4; and CHEMOKINE CCL5. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; MAST CELLS; and NK CELLS. The CCR5 receptor is used by the HUMAN IMMUNODEFICIENCY VIRUS to infect cells. Antigens, CD195,CC Chemokine Receptor 5,CCR5 Receptors,CD195 Antigens,CC-CKR5,CCR5 Receptor,CKR5 Receptors,Receptors, CKR5,Receptor, CCR5

Related Publications

Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
March 2004, Journal of virology,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
The y271 and i274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability.
July 2009, PloS one,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.
August 2012, Virology,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Resistance to human immunodeficiency virus type 1 protease inhibitors.
November 1998, Antimicrobial agents and chemotherapy,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies.
June 1996, The Journal of infectious diseases,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo.
January 1992, Current topics in microbiology and immunology,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Genotypic testing for human immunodeficiency virus type 1 drug resistance.
April 2002, Clinical microbiology reviews,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.
October 1991, Journal of virology,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1.
April 1994, European journal of biochemistry,
Lokesh Agrawal, and Qingwen Jin, and Jeff Altenburg, and L Meyer, and R Tubiana, and Ioannis Theodorou, and Ghalib Alkhatib
Resistance to inhibitors of the human immunodeficiency virus type 1 integration.
January 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
Copied contents to your clipboard!